Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (Weighted Average) (2016 - 2024)

Historic Shares Outstanding (Weighted Average) for Creative Medical Technology Holdings (CELZ) over the last 16 years, with Q3 2024 value amounting to $1.4 million.

  • Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) fell 175.82% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 million, marking a year-over-year decrease of 175.82%. This contributed to the annual value of $1.4 million for FY2023, which is 2876.21% up from last year.
  • Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) amounted to $1.4 million in Q3 2024, which was down 175.82% from $1.4 million recorded in Q2 2024.
  • Over the past 5 years, Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) peaked at $169.2 million during Q2 2020, and registered a low of $579461.0 during Q4 2020.
  • In the last 5 years, Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) had a median value of $1.4 million in 2024 and averaged $12.7 million.
  • The largest annual percentage gain for Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) in the last 5 years was 228382.76% (2020), contrasted with its biggest fall of 9995.47% (2020).
  • Creative Medical Technology Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $579461.0 in 2020, then surged by 349.57% to $2.6 million in 2021, then crashed by 58.04% to $1.1 million in 2022, then rose by 28.76% to $1.4 million in 2023, then decreased by 0.1% to $1.4 million in 2024.
  • Its last three reported values are $1.4 million in Q3 2024, $1.4 million for Q2 2024, and $1.4 million during Q1 2024.